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Introduction
Aortic aneurysm is a rare complication in patients
with rheumatoid arthritis (RA).1 We present a case of
multiple aortic aneurysms occurring heterochronically
in a RA patient with long-term steroid therapy.
Case Report
A 60-year-old woman was admitted to our hospital for
repair of a thoracoabdominal aortic aneurysm
(TAAA). When she was 45 years old, she had under-
gone straight graft replacement for an infra-renal
abdominal aortic aneurysm (AAA), in which the
pathological findings were compatible with athero-
sclerotic change.2 Preoperative evaluation at the first
operation detected no aneurysmal change in the
remaining aorta (Fig. 1A). Ten years after the oper-
ation, computed tomography (CT) revealed a TAAA
originating from the descending aorta down to the
proximal anastomosis of the implanted graft, with a
maximum diameter of 5 cm. Five years later, the
diameter had increased to 8 cm (Fig. 1B). Laboratory
data showed no active inflammation at this time.
She had been started on corticosteroid therapy at
the age of 18 years, because of the diagnosis of
systemic lupus erythematosus (SLE). Since her clinical
features altered later, the diagnosis was changed to
RA. All the while, she continued to take prednisolone,
and the total dose was 220 g. She also had a history of
hypertension which was well controlled, but had no
other risk factors for atherosclerosis.
Since the TAAA involved the celiac trunk, superior
mesenteric artery and bilateral renal arteries (Fig. 1C),
Dacron graft implantation and reconstruction of these
four visceral arteries were performed. Pathological
examination of the new aneurysm revealed lympho-
cytic infiltration, intimal fibrosis and disruption of the
medial elastic laminae.
Discussion
The unique feature of the present case is the rare nature
of TAAA recurrence after AAA repair. Plate et al.
reported that 0.46% of patients developed TAAA in
their follow-up study of 1087 patients who underwent
AAA repair.3 The young onset of primary AAA and the
absence of risk factors for atherosclerosis other than
hypertension are also uncommon features in this case.
We therefore speculated that other unknown factors also
played a role in the aneurysmal development.
One possible factor is a history of RA. Gravallese
et al. reported a prevalence of aortitis of 5.3% and of
aneurysmal formation of 1.6% among 188 autopsy
cases with RA.1 Pathological evaluation of the aortitis
cases revealed a combination of several findings, such
as inflammatory cell infiltration, medial necrosis,
disruption of elastic fibers, intimal fibrosis and
granulomas of the wall. In the present case, some of
these findings were observed, though they are
possibly detected in severe atherosclerosis.
Another possible factor in aneurysm development is
long-termsteroid therapy. It is known that corticosteroid
downregulates the synthesis of extracellular matrix
molecules,4 and destruction of connective tissues in the
arterialwall possibly initiates aneurysmsanddissection.
Previous case reports of SLE patients with corticostrer-
oid therapy showed aortic dissection and aneurysm
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with multiple small foci of medial necrosis, and steroid
therapy was suggested to initiate these lesions.2,5
Interestingly, in the above autopsy report of RA
cases, almost all aortitis patients had received corti-
costeroid therapy.1 In view of the above features, we
propose the possibility that coexistence of both RA and
steroid therapy indicates a high-risk situation for
aortic aneurysm.
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Fig. 1. Panel A shows an aortogram before graft replacement for infra-renal AAA, 15 years previously. Note no aneurysmal
change in the residual abdominal aorta (arrow). Panel B shows an aortogram of the newly formed TAAA immediately before
operation. The arrow head indicates the proximal anastomosis of the previously implanted graft, and the arrow indicates the
origin of TAAA. Panel C is a contrast-enhanced CT image at the level of the renal arteries. The asterisk indicates mural
thrombus in the aneurysm.
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